Semaglutide and muscle building: what TikTok gets wrong

What did @thesierra7 actually say?

Not much, medically speaking. The transcript is a single sentence about personal transformation: "I was willing to completely die to any form of me that I have been so that I can birth the woman that I was becoming." That's it. No dosing claims, no before-and-after numbers, no protocol advice. What she shared is a psychological reframe around identity change during a weight loss journey, not a medical tutorial.

To be fair to the creator, this kind of statement is common in behavioral change research. The idea that significant weight loss requires a shift in self-concept, not just habits, has real backing. But since the content is almost entirely motivational rather than instructional, there's a limit to how much medical fact-checking applies here.

Does the science back this up?

Surprisingly, yes, in a meaningful way. The idea that sustainable weight loss involves psychological identity change is well-supported. This isn't soft pop psychology. Researchers studying long-term weight maintenance have repeatedly found that people who keep weight off tend to adopt a new self-concept rather than viewing their old habits as a temporary pause.

Teixeira et al. (2015, Obesity Reviews) found that autonomous motivation and self-regulation, not external pressure, predicted long-term weight loss maintenance. Separately, work by Lillis et al. (2016, Journal of Consulting and Clinical Psychology) showed that acceptance-based behavioral therapy, which explicitly targets identity and self-perception, outperformed standard behavioral treatment for weight loss. On GLP-1 medications specifically, patients often report that the drug reduces food noise but that behavioral and psychological rewiring determines whether they sustain results. The medication changes appetite signaling. It doesn't automatically change who you think you are.

What did they get wrong (or right)?

She got the psychological framing right, and she deserves credit for that. The metaphor of "dying" to an old self maps closely onto what behavioral scientists call identity-based behavior change, a concept popularized in academic circles by researchers like James Prochaska and more recently discussed in the context of GLP-1 therapies.

What's missing, though, is any clinical grounding. The hashtags include "buildingmuscle" and "semigultide" (a misspelling of semaglutide), which implies she's using a GLP-1 medication alongside a resistance training program. That combination is actually clinically relevant and worth discussing. Research from Wilding et al. (2021, New England Journal of Medicine) showed semaglutide produces significant weight loss, but a meaningful portion of that loss can come from lean mass. Resistance training is one of the few evidence-based strategies to preserve muscle on GLP-1s. She's apparently doing both. She just didn't say so in the clip reviewed here.

What should you actually know?

If you're on a GLP-1 medication like semaglutide and you're not thinking about the psychological side of this process, you're working with half the toolkit. The drug suppresses appetite through hormonal signaling, primarily by acting on GLP-1 receptors in the hypothalamus and gut. But weight regain rates after stopping GLP-1 medications are high. Rubino et al. (2021, Diabetes, Obesity and Metabolism) found participants regained two-thirds of lost weight within a year of discontinuing semaglutide without ongoing behavioral support.

That's the clinical case for what @thesierra7 is describing intuitively. Identity change, building new habits, and reframing your relationship with food and your body aren't fluffy add-ons. They're the mechanism by which results persist after medication changes or stops. Anyone treating GLP-1 therapy as a standalone fix is reading the incomplete version of the evidence.

• Semaglutide is FDA-approved for chronic weight management under the brand name Wegovy at 2.4mg weekly dosing.
• Muscle preservation during GLP-1 therapy requires intentional resistance training and adequate protein intake.
• Behavioral and psychological support alongside medication improves long-term outcomes based on current evidence.
• Stopping GLP-1 medications without a maintenance plan is associated with significant weight regain.